Tools commonly used in the Psychiatry-Adult Child & Adolescent industry for day-to-day tasks and operations.

• Diagnostic and Statistical Manual of Mental Disorders (DSM)
• Beck Depression Inventory (BDI)
• Child Behavior Checklist (CBCL)
• Wechsler Intelligence Scale for Children (WISC)
• Hamilton Anxiety Rating Scale (HAM-A)
• Autism Diagnostic Observation Schedule (ADOS)
• Conners' Rating Scales
• Minnesota Multiphasic Personality Inventory (MMPI)
• Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
• Brief Psychiatric Rating Scale (BPRS)

Common products and services typical of NAICS Code 621112-07, illustrating the main business activities and contributions to the market.

• Depression treatment
• Anxiety management
• Bipolar disorder therapy
• Schizophrenia treatment
• ADHD diagnosis and treatment
• Eating disorder treatment
• Substance abuse treatment
• Post-traumatic stress disorder (PTSD) therapy
• Obsessive-compulsive disorder (OCD) treatment
• Autism spectrum disorder (ASD) diagnosis and treatment

The specific certifications, permits, licenses, and regulatory compliance requirements within the United States for this industry.

• Board Certification In Psychiatry: This certification is provided by the American Board of Psychiatry and Neurology (ABPN) and is required for psychiatrists to practice in the US. It ensures that the psychiatrist has completed the necessary education, training, and examination requirements to provide quality care to patients.
• DEA Registration: Psychiatrists who prescribe controlled substances must register with the Drug Enforcement Administration (DEA) to comply with federal regulations. This registration ensures that the psychiatrist is authorized to prescribe controlled substances and is complying with all regulations.
• State Medical License: Psychiatrists must obtain a medical license from the state in which they practice. This license ensures that the psychiatrist has met the necessary education, training, and examination requirements to practice medicine in that state.
• National Provider Identifier (NPI): Psychiatrists must obtain an NPI number to bill for services provided to patients. This number is a unique identifier that is used by healthcare providers and insurance companies to identify the provider and the services provided.
• HIPAA Compliance: Psychiatrists must comply with the Health Insurance Portability and Accountability Act (HIPAA) to protect patient privacy and ensure the security of patient information. This compliance includes training, policies, and procedures to safeguard patient information.

A concise historical narrative of NAICS Code 621112-07 covering global milestones and recent developments within the United States.

• The Psychiatry-Adult Child & Adolescent industry has a long and complex history. Psychiatry as a medical specialty began in the early 19th century, with the establishment of the first mental hospitals in Europe and the United States. The development of psychoanalysis in the late 19th and early 20th centuries marked a significant milestone in the field, as it introduced new methods of treating mental illness. In the mid-20th century, the introduction of psychotropic drugs revolutionized the treatment of mental illness, making it possible to manage symptoms more effectively. In recent years, the industry has seen a growing focus on evidence-based treatments, as well as an increasing emphasis on the integration of mental health care with primary care. In the United States, the industry has also been shaped by changes in healthcare policy, including the passage of the Affordable Care Act in 2010, which expanded access to mental health services for millions of Americans.

The anticipated future trajectory of the NAICS 621112-07 industry in the USA, offering insights into potential trends, innovations, and challenges expected to shape its landscape.

• Growth Prediction: Stable

  The future outlook for the Psychiatry-Adult Child & Adolescent industry in the USA is positive. The industry is expected to grow due to the increasing demand for mental health services. The COVID-19 pandemic has also increased the need for mental health services, which is expected to continue in the future. The industry is also expected to benefit from the increasing acceptance of mental health services and the growing awareness of mental health issues. The industry is also expected to benefit from the increasing use of telemedicine, which allows patients to receive mental health services remotely. The industry is also expected to benefit from the increasing use of technology in mental health services, such as the use of artificial intelligence and machine learning. Overall, the Psychiatry-Adult Child & Adolescent industry is expected to grow in the future due to the increasing demand for mental health services and the increasing use of technology in mental health services.

Recent groundbreaking advancements and milestones in the Psychiatry-Adult Child & Adolescent industry, reflecting notable innovations that have reshaped its landscape.

• Telepsychiatry: Telepsychiatry is the use of telecommunication and information technologies to provide psychiatric services remotely. This innovation has allowed patients to receive mental health services from the comfort of their homes, which has increased access to mental health services.
• Digital Therapeutics: Digital therapeutics are evidence-based therapeutic interventions that use digital and online health technologies to treat mental health conditions. This innovation has allowed patients to receive mental health services remotely and has increased access to mental health services.
• Collaborative Care: Collaborative care is a model of care that involves a team of healthcare professionals working together to provide comprehensive care to patients with mental health conditions. This innovation has improved the quality of care for patients with mental health conditions.
• Personalized Medicine: Personalized medicine is an approach to healthcare that involves tailoring medical treatment to the individual characteristics of each patient. This innovation has allowed for more effective and efficient treatment of mental health conditions.
• Mindfulness-Based Interventions: Mindfulness-based interventions are a type of therapy that involves teaching patients to be more aware of their thoughts and feelings. This innovation has been shown to be effective in treating a variety of mental health conditions.